冷沉淀与新鲜冰冻血浆中凝血因子含量比较

王甜甜 ,  乔翠翠 ,  王贺贺 ,  王惜媛 ,  王杰 ,  贺韦东 ,  孙昌魁 ,  房云海

中国输血杂志 ›› 2026, Vol. 39 ›› Issue (9) : 1286 -1289.

PDF (1142KB)
中国输血杂志 ›› 2026, Vol. 39 ›› Issue (9) : 1286 -1289. DOI: 10.13303/j.cjbt.issn.1004-549x.2026.09.018
论著

冷沉淀与新鲜冰冻血浆中凝血因子含量比较

作者信息 +

Comparison of coagulation factor levels in cryoprecipitate and corresponding fresh frozen plasma

Author information +
文章历史 +
PDF (1168K)

摘要

目的 分析冷沉淀与对应新鲜冰冻血浆中各凝血因子含量并进行比较,为冷沉淀的临床精准输注提供依据。方法 对 400 mL 全血制备的冷沉淀及对应的新鲜冰冻血浆进行纤维蛋白原、凝血因子Ⅱ、Ⅴ、Ⅶ、Ⅷ、Ⅸ、Ⅹ、Ⅺ、Ⅻ、ⅩⅢ、血管性血友病因子抗原(VWF∶Ag)、血管性血友病因子活性(VWF∶Act)检测,统计各凝血因子水平并进行配对比较,同时计算出每袋冷沉淀和新鲜冰冻血浆的凝血因子总含量。结果 冷沉淀中纤维蛋白原水平为(4.48±0.83)g/L,凝血因子Ⅷ活性为(330.11±172.00)IU/dL,VWF∶Ag为(510.7±229.34)IU/dL,VWF∶Act为(341.35±116.21)IU/dL。每袋冷沉淀(47.7±1.68)mL中纤维蛋白原含量为(211.94±39.6)mg、凝血因子Ⅷ含量为(156.67±79.82)IU、VWF∶Ag含量为(245.18±103.25)IU、VWF∶Act含量为(164.21±54.30)IU。通过冷沉淀与新鲜冰冻血浆的配对比较,发现冷沉淀中 Fib、FⅧ、FⅨ、FⅪ、FⅫ、FⅩⅢ、VWF∶Ag、VWF∶Act的浓度均高于新鲜冰冻血浆,差异有统计学意义(P值<0.05)。结论 新鲜冰冻血浆、冷沉淀均可作为凝血因子缺乏患者的治疗选择。结果可为临床精准选择血液制品、合理用血提供数据参考。

Abstract

Objective To analyze and compare the levels of various coagulation factors in cryoprecipitate and corresponding fresh frozen plasma, thereby providing a basis for the precise clinical administration of cryoprecipitate. Methods Fibrinogen, coagulation factors Ⅱ, Ⅴ, Ⅶ, Ⅷ, Ⅸ, Ⅹ, Ⅺ, Ⅻ, and ⅩⅢ, von Willebrand factor antigen (VWF∶Ag), and von Willebrand factor activity (VWF∶Act) were measured in cryoprecipitate and corresponding fresh frozen plasma prepared from 400 mL of whole blood. The levels of each coagulation factor were quantified and subjected to paired comparisons; the total coagulation factor content was also calculated for each bag of cryoprecipitate and fresh frozen plasma. Results The fibrinogen level in the precipitate was (4.48±0.83) g/L, coagulation factor Ⅷ activity was (330.11±172.00) IU/dL, VWF∶Ag was (510.7±229.34) IU/dL, VWF∶Act was (341.35±116.21) IU/dL; the activities of other coagulation factors did not differ significantly from those in fresh frozen plasma. In each bag of cryoprecipitate (47.7±1.68) mL, the fibrinogen content was (211.94±39.6) mg, the coagulation factor Ⅷ content was (156.67±79.82) IU, the VWF∶Ag content was (245.18±103.25) IU, VWF∶Act was (164.21±54.30) IU. Paired comparisons between cryoprecipitate and fresh frozen plasma revealed that the concentrations of Fib, FⅧ, FⅨ, FⅪ, FⅫ, FⅩⅢ, VWF∶Ag, and VWF∶Act in cryoprecipitate were all higher than those in fresh frozen plasma, with statistically significant differences (P<0.05). Conclusion Fresh frozen plasma and cryoprecipitate can serve as treatment options for patients with coagulation factor deficiencies. The results provide data to guide the precise selection of blood products and the rational use of blood in clinical practice.

关键词

冷沉淀 / 新鲜冰冻血浆 / 凝血因子 / 血管性血友病因子 / 精准输血

Key words

cryoprecipitate / fresh frozen plasma / coagulation factors / von Willebrand factor / precision transfusion

引用本文

引用格式 ▾
王甜甜,乔翠翠,王贺贺,王惜媛,王杰,贺韦东,孙昌魁,房云海. 冷沉淀与新鲜冰冻血浆中凝血因子含量比较[J]. 中国输血杂志, 2026, 39(9): 1286-1289 DOI:10.13303/j.cjbt.issn.1004-549x.2026.09.018

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

O'SHAUGHNESSY D F, ATTERBURY C, BOLTON MAGGS P, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant[J].Br J Haematol, 2004,126(1):11-28.

[2]

孙昌魁,王甜甜,王杰,等. 冷沉淀在罕见出血性疾病中的精准输注[J].中国输血杂志,2025,38(9):1150-1153+1161.

[3]

SUN C K, WWANG T T, WANG J, et al. Precision Transfusion for Cryoprecipitate in Rare Bleeding Disorders[J].Chin J Blood Transfusion,2025,38(9):1150-1153+1161.

[4]

国家卫生健康委. 血站技术操作规程(2019版)国卫医函〔2019〕98号[S].2019.

[5]

National Health Commission. Technical Operating Procedures for Blood Banks (2019 Edition). National Health Commission Medical Affairs Letter[2019] No. 98[S].2019.

[6]

国家卫生健康委. 血站技术操作规程(2015版)[S].2015.

[7]

National Health Commission. Technical Operating Procedures for Blood Banks (2015 Edition)[S].2019.

[8]

国家卫生健康委. 全血和成分血使用 WS/T 623-2018.

[9]

National Health Commission.WS/T 623-2018:Use of Whole Blood and Blood Components.

[10]

黄华霖,刘伟平,冯叶,等. 新版血站技术操作规程离心法制备的冷沉淀凝血因子FⅧ和血浆纤维蛋白原含量分析[J].分子诊断与治疗杂志,2022,14(10):1688-1691.

[11]

HUANG H L, LIU W P, FENG Y, et al. Analysis of coagulation factor Ⅷ and plasma fibrinogen concentrations in cryoprecipitate prepared by the centrifugation method according to the new edition of the technical operating procedures for blood banks[J].Journal of Molecular Diagnosis and Therapy, 2022, 14(10):1688-1691.

[12]

GREEN L, BOLTON-MAGGS P, BEATTIE C, et al. British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products:their handling and use in various patient groups in the absence of major bleeding[J].Br J Haematol, 2018,181(1):54-67.

[13]

KHAN J, DUNBAR NM. Time to stop worrying about ABO incompatible cryoprecipitate transfusions in adults[J].Transfusion, 2021,61(1):1-4.

[14]

SAHOO D, SILWAL P. Effect of cryoprecipitate transfusion without ABO group consideration:A nightmare experience[J].Asian J Transfus Sci, 2022,16(1):140-143.

[15]

房云海,程彦,张心声. 血友病治疗与输血医学[J].中国输血杂志,2025,38(2):168-171.

[16]

FANG Y H, CHENG Y, ZHANG X S. Hemophilia Treatment and Transfusion Medicine[J].CHIN J BLOOD TRANSFUSION,2025,38(2):168-171.

[17]

中华医学会血液学分会血栓与止血学组. 血管性血友病诊断与治疗中国指南(2022年版)[J].中华血液学杂志,2022,43(1):1-6.

[18]

Thrombosis and Hemostasis Working Group, Hematology Branch, Chinese Medical Association. Chinese Guidelines for the Diagnosis and Treatment of Hemophilia (2022 Edition)[J].Chin J Hematol,2022, 43(1):1-6.

[19]

汤姆森,索比拉杰-蒂格,斯科特,等. 延长冷沉淀物解冻后的存活期[J].输血,2021,61(5):1578-1585.

[20]

THOMSON C, SOBIERAJ-TEAGUE M, SCOTT D, et al. Extending the post-thaw viability of cryoprecipitate.[J].Transfusion,2021,61(5):1578-1585.

[21]

中华医学会血液学分会血栓与止血学组,中国血友病协作组. 罕见遗传性出血性疾病诊断与治疗中国专家共识(2021年版)[J].中华血液学杂志,2021,42(2):89-96.

[22]

Thrombosis and Hemostasis Working Group of the Hematology Branch of the Chinese Medical Association; China Hemophilia Consortium. Chinese Expert Consensus on the diagnosis and treatment of rare hereditary bleeding disorders (2021 Edition)[J].Chin J Hematol, 2021, 42(2):89-96.

[23]

CAUDILL J S, NICHOLS W L, PLUMHOFF E A, et al. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma[J].Transfusion,2009,49(4):765-770.

基金资助

山东省医药卫生发展项目(202503041160)

AI Summary AI Mindmap
PDF (1142KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉